XML 28 R18.htm IDEA: XBRL DOCUMENT
v3.22.4

Fair Value Considerations | 6 Months Ended
--- | ---
Dec. 31, 2022
Fair Value Disclosures [Abstract] |
Fair Value Considerations | 12. Fair Value Considerations We determine the fair value of financial and non-financial assets and liabilities using the fair value hierarchy, which establishes three levels of inputs that may be used to determine fair value as follows:
| ● | Level 1: Inputs that reflect unadjusted quoted prices in active markets that are accessible to Aytu for identical assets or liabilities;
| ● | Level 2: Inputs that include quoted prices for similar assets and liabilities in active or inactive markets or that are observable for the asset or liability either directly or indirectly; and
| ● | Level 3: Unobservable inputs that are supported by little or no market activity.
The Company’s financial instruments include cash and cash equivalents, accounts receivable, accounts payable, accrued liabilities, derivative warrant liabilities, contingent consideration liabilities, and short-term and long-term debt. The carrying amounts of certain short-term financial instruments, including cash and cash equivalents, restricted cash, accounts receivable, accounts payable and accrued liabilities approximate their fair value due to their short maturities. Short-term and long-term debt are reported at their amortized costs on our condensed consolidated balance sheets. The remaining financial instruments and derivative warrant liabilities are reported on our consolidated balance sheets at amounts that approximate current fair values. The Company’s policy is to recognize transfers in and/or out of fair value hierarchy as of the date in which the event or change in circumstances caused the transfer. There were no transfers between Level 1, Level 2 and Level 3 in the periods presented. Recurring Fair Value Measurements The following table presents the Company’s financial assets and liabilities that were accounted for at fair value on a recurring basis as of December 31, 2022 and June 30, 2022, by level within the fair value hierarchy. ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | ​ | ​ | ​ | Fair Value Measurements at December 31, 2022
​ |  | Fair Value at December 31, |  | ​ |  | ​ |  | ​
​ | ​ | 2022 |  | (Level 1) |  | (Level 2) |  | (Level 3)
​ | ​ | (In thousands)
Liabilities: | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Contingent consideration |  | $ | 389 |  | $ | — |  | $ | — |  | $ | 389
CVR liability |  | ​ | 810 |  | ​ | — |  | ​ | — |  | ​ | 810
Derivative warrant liabilities | ​ | ​ | 4,155 |  | ​ | — |  | ​ | — |  | ​ | 4,155
Total | ​ | $ | 5,354 |  | $ | — |  | $ | — | ​ | $ | 5,354
​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | ​ | ​ | ​ | Fair Value Measurements at June 30, 2022
​ |  | Fair Value at June 30, |  | ​ |  | ​ |  | ​
​ | ​ | 2022 |  | (Level 1) |  | (Level 2) |  | (Level 3)
​ |  | (In thousands)
Liabilities: | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Contingent consideration | ​ | $ | 396 |  | $ | — |  | $ | — |  | $ | 396
CVR liability | ​ | ​ | 578 |  | ​ | — |  | ​ | — |  | ​ | 578
Derivative warrant liabilities | ​ | ​ | 1,796 | ​ | ​ | — | ​ | ​ | — | ​ | ​ | 1,796
Total | ​ | $ | 2,770 |  | $ | — |  | $ | — | ​ | $ | 2,770
​ ​ ​ Summary of Level 3 Input Changes The following table sets forth a summary of changes to those fair value measures using Level 3 inputs for the six months ended December 31, 2022: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | CVR |  | Contingent | ​ | ​ | Derivative |  | ​ | Fixed Payment
​ | ​ | Liability | ​ | Consideration | ​ | ​ | Warrant Liabilities |  | ​ | Arrangement
​ | ​ | (In thousands)
Balance as of June 30, 2022 |  | $ | 578 | ​ | $ | 396 | ​ | $ | 1,796 | ​ | $ | 13,051
Included in earnings |  | ​ | 232 | ​ | ​ | (2) | ​ | ​ | (3,594) | ​ | ​ | 880
Purchases, issues, sales and settlements: |  |  | ​ | ​ | ​ | ​ | ​ |  | ​ | ​ | ​ | ​
Issues |  |  | — | ​ |  | — | ​ |  | 5,953 | ​ |  | —
Settlements |  |  | — | ​ |  | (5) | ​ |  | — | ​ |  | (2,050)
Balance as of December 31, 2022 |  | $ | 810 | ​ | $ | 389 | ​ | $ | 4,155 | ​ | $ | 11,881
​ Significant Assumptions Significant assumptions used in valuing CVRs were as follows:
​ | ​ | ​ | ​
​ | ​ | December 31,
​ |  | 2022
Leveraged Beta |  | 0.81 | ​
Market risk premium | ​ | 6.22 | %
Risk-free interest rate | ​ | 5.00 | %
Discount | ​ | 21.25 | %
Company specific discount |  | 10.00 | %
​ ​ ​ Significant assumptions used in valuing derivative warrant liabilities at issuance date were as follows:
​ | ​ | ​ | ​
​ | ​ | August 9,
​ |  | 2022
Expected volatility |  | 89.89 | %
Equivalent term (years) | ​ | 4.11 | ​
Risk-free rate | ​ | 3.09 | %
Dividend yield | ​ | 0.00 | %
​ Significant assumptions used in valuing derivative warrant liabilities were as follows:
​ | ​ | ​ | ​
​ | ​ | December 31,
​ |  | 2022
Expected volatility |  | 96.62 | %
Equivalent term (years) | ​ | 4.09 - 4.69 | ​
Risk-free rate | ​ | 4.02 - 4.11 | %
Dividend yield | ​ | 0.00 | %
​ ​ The fixed payment arrangements are recognized at their amortized cost basis using market appropriate discount rates and are accreted up to their ultimate face value over time.

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -URI https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258 + Details
Name: | us-gaap_FairValueDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration